Febuxostat: A selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. Epidemiology, risk factors, and lifestyle modifications for gout;Saag;Arthritis Res Ther.,2006
2. Gout in the UK and Germany: Prevalence, comorbidities and management in general practice 2000–2005;Annemans;Ann Rheum Dis.,2008
3. Chapter 87: Gout and hyperuricemia;Wortmann,2009
4. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study;Campion;Am J Med.,1987
5. Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects;Yu;Ann Intern Med.,1961
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Febuxostat ternary inclusion complex using SBE7-βCD in presence of a water-soluble polymer: physicochemical characterization, in vitro dissolution, and in vivo evaluation;Drug Delivery and Translational Research;2024-01-07
2. Molybdenum enzymes;Metalloenzymes;2024
3. Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application;Life;2023-11-11
4. Gout Treatment and Clinical Considerations: The Role of Pegloticase, Colchicine, and Febuxostat;Cureus;2023-10-07
5. Simultaneous and Ratiometric Electrochemical Determination of Uric Acid and Hypoxanthine Based on In Situ Carbonized Polydopamine Graphene Paper;ACS Applied Nano Materials;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3